
About Novaerus
Novaerus is a Healthcare company based in Chicago (United States) founded in 2011. Airborne pathogens are neutralized using plasma field technology. Novaerus has raised $25 million across 2 funding rounds from investors including Polaris Partners and F-Prime Capital. The company has 19 employees. Novaerus has completed 1 acquisition, including Plasma Air. Novaerus offers products and services including Defend 400 and Defend 1050. Its focus areas include Life Sciences, Hospital Equipment, Hospital Infection Control and Air Sanitization. Its legal entity is Novaerus, Inc.
Company details
Novaerus is a company that offers an airborne pathogen control technology to help improve quality of air. Novaerus scrubs the air using a unique plasma field to reduce airborne pathogens. Novaerus claims its clients can expect lowered re-hospitalizations and decreased antibiotic usage within one year of implementing the Novaerus technology. The technology eradicates all airborne viruses,bacteria, moulds and odours and destroys contaminants like MRSA, C-Diff, Norovirus and Influenza.
- Headquarters Chicago, United States
- Employees 19
- SectorsHealthcare
- Website novaerus.com
- Social LinkedIn X Facebook
- Legal Name Novaerus, Inc.
- Total Equity Funding$25M (USD)
in 2 rounds
- Latest Funding Round$15M (USD), Series B
Feb 2016
- InvestorsPolaris Partners
& 1 more
- Employee Count19
- Investments & Acquisitions
Products & Services of Novaerus
Novaerus offers a comprehensive portfolio of products and services, including Defend 400 and Defend 1050.
Inactivates viruses and purifies air in medium to large spaces.
Provides rapid remediation for large, high-risk environments.
Funding Insights of Novaerus
Novaerus has successfully raised a total of $25M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $15 million completed in February 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25M
- Total Rounds 2
- Last Round Series B β $15M
- First Round $10M
(Nov 2014)
- Investors Count 2
All 2 funding rounds of Novaerus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2016 | $15M | Series B | β | β | |
| Nov 2014 | $10M | Series A | β | β |
2 investors in total: 2 institutional.
Investors in Novaerus
Novaerus has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Polaris Partners and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US focused venture capital firm | polarispartners.com | Boston, United States | ||
Investments in life sciences, technology, healthtech, and crypto sectors from global locations. | fprimecapital.com |
Investor details for Novaerus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Novaerus
4 people are tracked at Novaerus (4 in board & advisors); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
Thomas Caranasos | Medical Board Member | Board & advisors |
Regina Benjamin | Medical Board Chair | Board & advisors |
David J. Weber | Medical Board Member | Board & advisors |
Daniel E. Dawes | Medical Board Member | Board & advisors |
Complete people profiles for Novaerus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Novaerus
Novaerus has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Plasma Air.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Air purification systems for buildings are manufactured using bipolar ionization. | plasma-air.com | 0 | Jun 2016 | β’β’β’β’ |
Complete acquisition details for Novaerus
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Novaerus
4 dated milestones of Novaerus across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Novaerus is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Series B, of $15.0M.
- Acquisition Acquires Plasma Air.
Web traffic of Novaerus
Websites that share an audience with Novaerus (novaerus.com).
Websites whose visitors overlap most with Novaerus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
conditions.healthguru.com | conditions.healthguru.com | 100% | β | ||
| everydayhealth.com | 52% | 5.4M | #13,496 | View details |
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as Novaerus (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 8.15 B | 6,357 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novaerus
Complete news archive for Novaerus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novaerus
Novaerus was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Novaerus is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Novaerus is a funded company, having raised a total of $25M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Nov 2014.
Novaerus has 19 employees.
Novaerus is a company that offers an airborne pathogen control technology to help improve quality of air. Novaerus scrubs the air using a unique plasma field to reduce airborne pathogens. Novaerus claims its clients can expect lowered re-hospitalizations and decreased antibiotic usage within one year of implementing the Novaerus technology. The technology eradicates all airborne viruses,bacteria, moulds and odours and destroys contaminants like MRSA, C-Diff, Norovirus and Influenza.
Novaerus offers Defend 400 and Defend 1050.
Novaerus has made 1 acquisition, including Plasma Air.
Novaerus has 2 investors. Key investors include Polaris Partners, and F-Prime Capital.
Novaerus operates through Novaerus, Inc..
